Corteva (CTVA) AI Stock Analysis

Corteva

(BMV:CTVA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong operating momentumStrong first-half sales, EBITDA and EPS growth shows effective execution across both core segments. The accompanying margin expansion and raised full-year outlook indicate that productivity, product mix and commercial performance may support earnings growth beyond a single reporting period.

Negative Factors

Weak recent revenue trendThe sharp trailing revenue contraction signals weaker recent demand or mix than the historical scale of the business would imply. If sustained, lower revenue can limit operating leverage, reduce reinvestment capacity and make the raised earnings outlook more dependent on margins and productivity.

Corteva (CTVA) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 7.77B
Dividend Yield: 0.67%
Average Volume (3M): 417
Price to Earnings (P/E): 51.3
Beta (1Y): 0.30
Revenue Growth: -6.69%
EPS Growth: -39.18%
Country: Mexico
Employees: 21,500
Sector: Basic Materials
Sector Strength: 61
Industry: Agricultural Inputs

Corteva Business Overview & Revenue Model

Company Description

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait techno...

Corteva Earnings Call Summary

Earnings Call Date:Jul 29, 2026(Q2-2026)|% Change Since:12.89%|Next Earnings Date:Nov 10, 2026

Earnings Call SentimentPositive

The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.

Positive Updates

Raised Full-Year Guidance

Operating EBITDA guidance increased to $4.1B–$4.3B and operating EPS to $3.60–$3.80. At the midpoint this implies ~9% EBITDA growth and ~11% EPS growth versus prior year.

Negative Updates

Crop Protection Pricing Pressure

Crop protection pricing under pressure, particularly in Latin America/Brazil. Company expects pricing decline in the second half of low-to-mid single digits (and noted pockets of more competitive pricing in Brazil).

Company Guidance

Corteva raised full‑year 2026 guidance, now expecting operating EBITDA of $4.1–$4.3 billion and operating EPS of $3.60–$3.80 (midpoints imply ~9% EBITDA growth and ~11% EPS growth versus last year) with an operating EBITDA margin target of 22.5%–23.5%; that outlook is supported by a strong first half (net sales $11.3B, +4% YoY, organic +2%; Q2 net sales $6.4B), first‑half operating EBITDA $3.7B (+10%), operating EPS +14%, and margin expansion of nearly 200 basis points to ~32.8%. Management assumes seed organic growth of low‑single digits, crop protection volumes up high‑single digits (driven by new products) with pricing down low‑ to mid‑single digits, Brazil corn area ~flat, and typical seasonality (a Q3 operating EBITDA loss similar to 2024 with most second‑half earnings in Q4); year‑to‑date drivers include >$160M of cost/productivity savings, ~$90M improvement in net royalties, and an ~$85M favorable currency impact, and absent one‑time items they expect free cash flow conversion in line with prior midterm targets.

Corteva Risk Analysis

Corteva disclosed 31 risk factors in its most recent earnings report. Corteva reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk

1.Our business, financial condition and results of operations could be materially affected by disruptions in the global economy caused by the ongoing conflict between Russia and Ukraine.Q3, 2022

Corteva Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

MX:CTVA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CF	80Outperform	$18.66B	9.12	40.41%	1.70%	20.04%	76.29%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ICL	60Neutral	$5.91B	18.76	5.02%	4.50%	10.92%	-16.91%
MOS	43Neutral	$5.85B	91.95	0.36%	4.79%	8.84%	-167.87%
FMC	42Neutral	$964.39M	-0.19	-308.88%	5.16%	-21.99%	-677.23%
BIOX	34Underperform	$13.15M	-0.06	-216.09%	―	-26.10%	14.85%

* Basic Materials Sector Average

Performance Comparison

MX:CTVA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MX:CTVA	Corteva	232.50	73.78	46.49%
CF	Cf Industries Holdings, Inc.	123.30	40.47	48.85%
FMC	FMC Corp	6.20	-6.86	-52.53%
MOS	Mosaic Co	18.39	-7.22	-28.19%
ICL	Icl Group Ltd.	4.58	-1.78	-27.96%
BIOX	Bioceres Crop Solutions	0.21	-1.56	-88.25%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Corteva AI Stock Analysis